Vibativ Injection, Powder, Lyophilized, For Solution
NDC Package 66220-315-22

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Vibativ (telavancin hydrochloride) injection is a medication an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. This formulation utilizes a injection, powder, lyophilized, for solution delivery system. Marketed by Cumberland Pharmaceuticals Inc., this product is identified by NDC 66220-315 and is authorized under FDA application NDA022110.

Identification & Billing

NDC Package Code
66220-315-22
Package Description
12 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE
Product Code
66220-315
11-Digit Billing Format
66220031522
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Vibativ
Non-Proprietary Name
Telavancin Hydrochloride
Substance Name
Telavancin Hydrochloride
Dosage Form
Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
TELAVANCIN HYDROCHLORIDE 15 mg/mL
Pharmacologic Class
Usage Information
This medication is an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. It works by stopping the growth of bacteria.

Regulatory & Marketing

Labeler Name
Cumberland Pharmaceuticals Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA022110
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-01-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Billing & HCPCS Mapping

To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.

J3095
Source: ASP
Telavancin injection
HCPCS Dosage 10 MG
Units / Pkg 900

Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (66220-315). Click a package code to view its specific billing and regulatory data.

66220-315-11
1 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE
66220-315-44
4 VIAL, SINGLE-DOSE in 1 CARTON / 50 mL in 1 VIAL, SINGLE-DOSE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66220-315-22 identifies a specific commercial package of 12 vial, single-dose in 1 carton / 50 ml in 1 vial, single-dose of Vibativ, a human prescription drug labeled by Cumberland Pharmaceuticals Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This injection, powder, lyophilized, for solution is formulated for intravenous use and contains telavancin hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cumberland Pharmaceuticals Inc. on January 01, 2021. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is an antibiotic used to treat serious bacterial infections of the skin and certain types of pneumonia. It works by stopping the growth of bacteria.

How is this Cumberland Pharmaceuticals Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66220031522. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66220-315-22
11-Digit CMS (5-4-2)
66220-0315-22

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.